| Product Code: ETC11272555 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market - Industry Life Cycle |
3.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market - Porter's Five Forces |
3.5 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular and neurological disorders in Sweden |
4.2.2 Technological advancements in in-vitro diagnostics for cardiology and neurology |
4.2.3 Growing demand for personalized medicine in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for medical devices in Sweden |
4.3.2 High cost associated with in-vitro diagnostics equipment and tests |
4.3.3 Limited reimbursement policies for in-vitro diagnostics procedures |
5 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Trends |
6 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market, By Types |
6.1 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Cardiac Biomarkers, 2021 - 2031F |
6.1.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurological Biomarkers, 2021 - 2031F |
6.1.5 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Genetic Markers, 2021 - 2031F |
6.1.6 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Troponin, 2021 - 2031F |
6.2.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Amyloid Beta, 2021 - 2031F |
6.2.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By APOE Testing, 2021 - 2031F |
6.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Heart Attack Detection, 2021 - 2031F |
6.3.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Alzheimer's Diagnosis, 2021 - 2031F |
6.3.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Stroke Risk Assessment, 2021 - 2031F |
6.3.5 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurodegenerative Disorders, 2021 - 2031F |
6.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.4.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Import-Export Trade Statistics |
7.1 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Export to Major Countries |
7.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Imports from Major Countries |
8 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Key Performance Indicators |
8.1 Adoption rate of new in-vitro diagnostic technologies in cardiology and neurology |
8.2 Rate of integration of in-vitro diagnostics in routine clinical practice |
8.3 Number of research collaborations and partnerships in the field of in-vitro diagnostics for cardiology and neurology |
9 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market - Opportunity Assessment |
9.1 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market - Competitive Landscape |
10.1 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Revenue Share, By Companies, 2024 |
10.2 Sweden In-Vitro Diagnostics for Cardiology and Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here